A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant fo (Q77684754)
scientific article published on 01 November 1998
Language:
(P31) (Q13442814)
(P304) 3023-3031
(P433) 11
(P478) 13
(P577) Sunday, November 1, 1998
(P1433) (Q5937357)
(P1476) "A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group" (language: en)
other details
description scientific article published on 01 November 1998

External Links